I have been wanting to post the factual data for sometime on the ucla study comparing dcvax (they called this placebo), to dcvax+ poly-iclc, and dcvax+resiquimod. Some here have claimed adding poly-iclc gave 50% 5 year survival.
I found Senti pretty much did most all the work already in post #631339 but I will add a bit.
There were 15 gbm patients, 4 got dcvax, 5 got dcvax+ poly-iclc, and 6 got dcvax+resiquimod
I will show the MGMT methylated with (m).
All figures are for months of OS
Dcvax - 5.5, 7.0, 14.4, 61.2(m)
Dc+poly - 24.5, 26.6, 28.6, 28.6, 52.5(m)
Dc+resiq -13.1, 16.1(m), 16.7, 19.3, 33.3, 43.3(m)
Imo addition of poly-iclc did very well but clearly not 50% 5 year survival not sure where people are getting that
MGMT - methylation clearly makes a difference
One patient of the 15 survived 5 years from the 'placebo' group
Thanks to Senti for already having all the data